Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Interim clinical data on varenicline for smoking cessation in bipolar depression disclosed

March 19, 2010

Nabi initiates second phase III trial of nicotine conjugate NicVAX vaccine

March 18, 2010

Protalix initiates phase I trial of PRX-105 acetylcholinesterase for biodefense indications

March 18, 2010

Sanofi-aventis patents new cannabinoid CB1 receptor antagonists

March 10, 2010

Nabi and GSK close NicVAX option and license agreement

March 9, 2010

Nabi stockholders approve NicVAX option and license agreement

March 4, 2010

BTG and Paladin complete agreement for DigiFab for digoxin toxicity

Feb. 26, 2010

Cleveland BioLabs responds to Department of Defense RFP for CBLB-502

Feb. 25, 2010

Catalyst and NIDA to initiate phase IIb trial of CPP-109 for cocaine addiction

Feb. 24, 2010

Embera and Exponential sign clinical development agreement for EMB-001C

Feb. 17, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...